Offer an initial follow-up appointment at 3 months after starting treatment, or earlier depending on severity of symptoms, or at 1 month if pregnant or breastfeeding NICE NG239.
At each follow-up, ask the person if their symptoms have improved, worsened, or if they are experiencing new symptoms linked to vitamin B12 deficiency NICE NG239.
For people taking oral vitamin B12, check they are taking the correct dosage; if symptoms have not sufficiently improved, consider increasing the dose to the maximum licensed dosage or switching to intramuscular injections NICE CKS.
In cases of intramuscular treatment, do not repeat the initial diagnostic test; instead, monitor symptoms and consider further testing if symptoms worsen or new symptoms develop NICE NG239.
Assess for resolution of symptoms and consider stopping or reducing treatment if symptoms have resolved or improved and the cause has been addressed, with advice to return if symptoms reappear or worsen NICE NG239.